Loading company…
Vaxcyte, Inc. develops vaccines against bacterial infections, including its VAX-31 and VAX-24 pneumococcal conjugate vaccines.
The company is also working on vaccines for Group A Streptococcus, periodontitis and Shigella. Founded in 2013 and headquartered in San Carlos, US, Vaxcyte was co-founded by Grant Pickering and Jeff Fairman and is at the Series D stage after 10 funding deals. Its latest round was a Private Placement in April 2023 that raised USD 500.00 mn, bringing the total raised to USD 500.00 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in